For Cupertino, California residents, geographic distance from mainland pharmacies has historically affected access to specialty medications. Mounjaro® is the FDA-approved Injectable pen Tirzepatide product manufactured by Eli Lilly; Pacific-region retail pricing varies by pharmacy. Weight Method offers a separate telehealth program: licensed California providers evaluate eligible patients and prescribe compounded Tirzepatide, dispensed by a U.S.-licensed 503A pharmacy. Compounded Tirzepatide is not FDA-approved. The Weight Method program is priced at $329/month uniformly, shipped directly to your Cupertino address.
FDA-approved Mounjaro prescribed by licensed providers. Delivered to your door.
Free consultation · No commitment · Results in weeks
From 2,000+ patients · Cupertino is already seeing results
Mounjaro in Cupertino, CA: an FDA-approved GLP-1 medication shown to achieve 15-22% body weight loss in clinical trials. Weight Method offers Mounjaro to patients in Cupertino from $329/month with virtual consultations and direct-to-door shipping.
Tirzepatide targets the biological mechanisms involved in sustained weight regulation. By activating GLP-1 receptors in the brain, it can reduce hunger signals and slow gastric emptying. Eli Lilly developed Mounjaro® as the FDA-approved Injectable pen product, taken Once weekly, approved in 2022. Weight Method is a separate program: licensed providers in California evaluate eligible patients via telehealth and prescribe compounded Tirzepatide, dispensed by a U.S.-licensed 503A pharmacy. Compounded Tirzepatide is not FDA-approved. The Weight Method program for eligible Cupertino, CA residents starts at $329/month.
Hispanic adults in Cupertino face disproportionately high rates of obesity and type 2 diabetes — conditions that Tirzepatide therapy is studied for. Weight Method removes barriers that have historically limited access: our platform is fully bilingual, and our compounded Tirzepatide program (dispensed by a U.S.-licensed 503A pharmacy; compounded Tirzepatide is not FDA-approved) starts at $329/month with no insurance needed. Everything happens virtually from your Cupertino home.
Compounded GLP-1 medications dispensed by U.S.-licensed 503A pharmacies.

Compounded semaglutide. Once-weekly subcutaneous injection.

Compounded tirzepatide. Dual-action GLP-1/GIP, once-weekly subcutaneous injection.
Consult with a licensed provider in California and start Mounjaro from $329/month.
Get Started NowFree consultation. No commitment.